— Know what they know.
Not Investment Advice

SPEC.L LSE

INSPECS Group plc
1W: -1.1% 1M: -3.6% 3M: -4.6% YTD: +24.2% 1Y: +110.2% 3Y: -8.4% 5Y: -74.8%
£94.50 ($1.25)
+2.00 (+2.16%)
 
Weekly Expected Move ±1.4%
£90 £91 £92 £94 £95
LSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 46 · £103.2M mcap · 62M float · 0.012% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap£103.2M ($1.4M)
52W Range40-105
Volume0
Avg Volume7,488
Beta1.60
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORichard David Peck
Employees1,656
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2020-02-27
7-10 Kelso Place
Bath, SO BA1 3AU
GB
44 12 2571 7000
About INSPECS Group plc

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT, Free Country, Henri Lloyd, Hype, JOSEPH, Lamb, Liberty, Lyle & Scott, Marc O’Polo, MINI, O’Neill, SUPERDRY, RADLEY LONDON, TALBOT RUNHOF, Ted Baker, Temperley LONDON, and Victor Rolf; and in house brands under BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY’S eyewear, JOS ESCHENBACH, and TITANFLEX names. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms